Related Experiment Video
Updated: Jun 16, 2026
09:54
Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
[Transfusion-related acute lung injury]
J M Añón1, A García de Lorenzo, M Quintana
1Servicio de Medicina Intensiva, Hospital Virgen de la Luz, Cuenca, Castilla-La Mancha, España. jmaelizalde@telefonica.net
Medicina Intensiva
|February 17, 2010
Summary
Transfusion-Related Acute Lung Injury (TRALI) is a rare, fatal syndrome causing respiratory failure after blood transfusions. Understanding its antibody-mediated or two-event causes is key to prevention strategies.
Area of Science:
- Hematology
- Pulmonary Medicine
- Immunology
Background:
- Transfusion-Related Acute Lung Injury (TRALI) is a critical clinical syndrome.
- It presents as acute respiratory failure and non-cardiogenic pulmonary edema post-transfusion.
- TRALI is a leading cause of transfusion-related fatalities in the USA.
Purpose of the Study:
- To define Transfusion-Related Acute Lung Injury (TRALI).
- To elucidate the proposed etiologies of TRALI.
- To outline current patient management and prevention strategies for TRALI.
Main Methods:
- Literature review and synthesis of existing knowledge on TRALI.
- Analysis of proposed etiological models for TRALI.
- Summary of clinical management and preventative measures.
Main Results:
- TRALI is characterized by acute respiratory failure following blood transfusion.
- Two primary etiologies are proposed: single antibody-mediated events and a two-event model involving patient condition and transfusion products.
- Management is supportive, with prevention focused on donor selection and transfusion practices.
Conclusions:
- TRALI necessitates a thorough understanding of its complex pathophysiology.
- Effective prevention strategies are crucial for patient safety in transfusion medicine.
- Further research may refine understanding and management of TRALI.
Related Concept Videos
01:21Acute Respiratory Failure-II
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
01:21Acute Respiratory Failure-I
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
01:26Pneumothorax-I
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
01:29Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:23Acute Respiratory Failure-IV
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
01:30Acute Respiratory Failure-III
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...